Michel Sadelain, one of the fathers of CAR-T, the promising therapies against cancer: "They are living medications that multiply within the patient's body"
Michel Sadelain, a key figure in CAR-T therapy, discusses the advancements in cancer treatment and the ongoing challenges in targeting solid tumors.
Trained defenses attack the 'castle' of solid tumors: CAR-T therapies find weaknesses in the kidney, ovary, and pancreas
Recent advances in CAR-T therapy show potential for effectively targeting solid tumors in organs such as the kidney, ovary, and pancreas, addressing a significant challenge in cancer treatment.
If outpatient treatment exceeds 300 times a year, the cost responsibility rate will rise to 90%... Immunotherapy for bile duct cancer included in health insurance
A new plan in South Korea proposes increasing the personal cost responsibility rate for outpatient treatments exceeding 300 visits annually to 90%, while also expanding health insurance coverage for immunotherapies for bile duct cancer.
Initial success of a personalized vaccine against triple-negative breast cancer, the most aggressive
A clinical trial shows promising results for a personalized vaccine targeting triple-negative breast cancer, with hopes for approval within four years.
Injectable immunotherapies: how the new cancer treatments already being used in the country work
Argentina is embracing a new trend in cancer treatment with injectable immunotherapies, recently approved to provide a more convenient alternative to traditional intravenous chemotherapy.
Hockey players raise funds to expand CAR T-cell therapy access in Edmonton
Hockey players at the World’s Longest Hockey Game are fundraising to support CAR T-cell therapy access at Edmonton's Cross Cancer Institute.
The scientists who have revolutionized treatment for different types of blood cancer win the Fronteras prize
American oncologist Carl June and French geneticist Michel Sadelain have been awarded the BBVA Foundation's Fronteras del Conocimiento Prize for their innovative CAR-T cell therapy for blood cancers.
The parents of CAR T therapies against cancer receive the BBVA Foundation Frontiers of Knowledge Award in Biomedicine
Researchers Carl June and Michel Sadelain have been awarded the BBVA Foundation Frontiers of Knowledge Award in Biomedicine for their pioneering work in CAR-T cell therapies that transform cancer treatment.
International research involving Greece proposes innovative treatment for hematological cancers
An international research initiative including Greek scientists proposes a novel immunotherapy treatment for blood cancers using modified CAR-T cells.
Cancer: Argentina approves an immunotherapy for solid tumors that is administered through injections
Argentina's ANMAT has approved a new anti-PD-1 immunotherapy that can be administered via injections in three to five minutes, maintaining the efficacy of intravenous delivery.
OAUTH unveils Nigeria’s first immunotherapy trial for colorectal cancer
The Obafemi Awolowo University Teaching Hospital has launched Nigeria's first clinical trial for colorectal cancer treatment, offering free treatments in partnership with major hospitals.
Researchers target tumor protection function with new immunotherapy
A research team from the USA has developed a new immunotherapy that removes a previously overlooked protective mechanism of tumors, showing promising results, though so far only in the lab.